T 1627/18 (Liposomes with lipids having an advantageous pKa-value for RNA delivery / GLAXOSMITHKLINE) of 16.12.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T162718.20201216
- Date of decision
- 16 December 2020
- Case number
- T 1627/18
- Online on
- 21 December 2020
- Petition for review of
- -
- Application number
- 11736500.7
- IPC class
- A61K 39/00C12N 15/86A61K 9/127
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- Dennemeyer & Associates S.A.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(2) (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)European Patent Convention Art 100(a) (2007)European Patent Convention R 84(2) (2007)
- Keywords
- Novelty - main request (yes)
Remittal - special reasons for remittal - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0606/22
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.